Found: 21
Select item for more details and to access through your institution.
MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1006, doi. 10.1177/13524585211010070
- By:
- Publication type:
- Article
MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses – Yes.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1002, doi. 10.1177/13524585211001789
- By:
- Publication type:
- Article
MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses – No.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1004, doi. 10.1177/13524585211001564
- By:
- Publication type:
- Article
Cognitive dysfunction and fatigue during relapses: Taking a better look.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 989, doi. 10.1177/1352458521999970
- By:
- Publication type:
- Article
Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1077, doi. 10.1177/1352458520973618
- By:
- Publication type:
- Article
'Posture second' strategy predicts disability progression in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1140, doi. 10.1177/1352458520963926
- By:
- Publication type:
- Article
High-intensity interval training reduces neutrophil-to-lymphocyte ratio in persons with multiple sclerosis during inpatient rehabilitation.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1136, doi. 10.1177/1352458520951382
- By:
- Publication type:
- Article
Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1066, doi. 10.1177/1352458520949986
- By:
- Publication type:
- Article
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1088, doi. 10.1177/1352458520943788
- By:
- Publication type:
- Article
The central vein sign in multiple sclerosis patients with vascular comorbidities.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1057, doi. 10.1177/1352458520943785
- By:
- Publication type:
- Article
Depression is associated with disconnection of neurotransmitter-related nuclei in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1102, doi. 10.1177/1352458520948214
- By:
- Publication type:
- Article
Clinical and MRI characteristics of multiple sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1027, doi. 10.1177/1352458520948212
- By:
- Publication type:
- Article
Conscientiousness and deterioration in employment status in multiple sclerosis over 3 years.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1125, doi. 10.1177/1352458520946019
- By:
- Publication type:
- Article
Inflammatory activity following motor progression due to critical CNS demyelinating lesions.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1037, doi. 10.1177/1352458520948745
- By:
- Publication type:
- Article
Autofluorescence spectroscopy as a proxy for chronic white matter pathology.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1046, doi. 10.1177/1352458520948221
- By:
- Publication type:
- Article
Methylome and transcriptome signature of bronchoalveolar cells from multiple sclerosis patients in relation to smoking.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1014, doi. 10.1177/1352458520943768
- By:
- Publication type:
- Article
What's in a name? That which we call Multiple Sclerosis Fatigue.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 983, doi. 10.1177/1352458520941481
- By:
- Publication type:
- Article
Thoracic flexion provokes circumferential dysesthesia: A symptom of thoracic cord lesions in MS.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1008, doi. 10.1177/1352458520932476
- By:
- Publication type:
- Article
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1145, doi. 10.1177/1352458520914818
- By:
- Publication type:
- Article
High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1112, doi. 10.1177/1352458520943087
- By:
- Publication type:
- Article